Paper39202808
Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation.
Zhang G and 5 others. Molecules, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation. Papers, record 39202808. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39202808
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of Cutaneous TRPV3 Channels by Natural Caffeic Acid for the Alleviation of Skin Inflammation.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Caffeic Acids | Major topic |
| TRPV Cation Channels | Major topic |
| Molecular Docking Simulation | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Skin | |
| Cymenes | |
| HEK293 Cells | |
| Anti-Inflammatory Agents | |
| Inflammation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZR2023MH081 | Natural Science Foundation of Shandong Province | PubMed | ||
| 81903734; 81973299 | National Natural Science Foundation of China | PubMed | ||
| 2018ZX09711001-004-006 | Ministry of Science and Technology of China | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35771623 | Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/35771623 | PubMed |
| 2 | 33501656 | A plant-derived TRPV3 inhibitor suppresses pain and itch. | Br J Pharmacol | 2021 | https://conductscience.org/library/papers/33501656 | PubMed |
| 3 | 28377424 | The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases. | Mol Pharmacol | 2017 | https://conductscience.org/library/papers/28377424 | PubMed |
| 4 | 33876725 | Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine. | Elife | 2021 | https://conductscience.org/library/papers/33876725 | PubMed |
| 5 | 22405088 | Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. | Am J Hum Genet | 2012 | https://conductscience.org/library/papers/22405088 | PubMed |
| 6 | 34472684 | Structural mechanism of TRPV3 channel inhibition by the plant-derived coumarin osthole. | EMBO Rep | 2021 | https://conductscience.org/library/papers/34472684 | PubMed |
| 7 | 35256942 | Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35256942 | PubMed |
| 8 | 36677834 | TRPV3: Structure, Diseases and Modulators. | Molecules | 2023 | https://conductscience.org/library/papers/36677834 | PubMed |
| 9 | 35038353 | Transient receptor potential vanilloid 3 expression is increased in non-lesional skin of atopic dermatitis patients. | Exp Dermatol | 2022 | https://conductscience.org/library/papers/35038353 | PubMed |
| 10 | 34245864 | Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/34245864 | PubMed |
| 11 | 38043155 | Inhibition of Ca2+-permeable TRPV3 and inflammatory cytokine release by honokiol and magnolol in human epidermal keratinocytes. | Biochem Biophys Res Commun | 2024 | https://conductscience.org/library/papers/38043155 | PubMed |
| 12 | 29802912 | Caffeic acid prevents UVB radiation induced photocarcinogenesis through regulation of PTEN signaling in human dermal fibroblasts and mouse skin. | Toxicol Appl Pharmacol | 2018 | https://conductscience.org/library/papers/29802912 | PubMed |
| 13 | 36302896 | Structural basis of TRPV3 inhibition by an antagonist. | Nat Chem Biol | 2023 | https://conductscience.org/library/papers/36302896 | PubMed |
| 14 | 31234539 | Caffeic Acid Phenethyl Ester Inhibits UV-Induced MMP-1 Expression by Targeting Histone Acetyltransferases in Human Skin. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31234539 | PubMed |
| 15 | 33035568 | Novel insights into the TRPV3-mediated itch in atopic dermatitis. | J Allergy Clin Immunol | 2021 | https://conductscience.org/library/papers/33035568 | PubMed |
| 16 | 31983608 | Anti-pruritic and anti-inflammatory effects of natural verbascoside through selective inhibition of temperature-sensitive Ca2+-permeable TRPV3 channel. | J Dermatol Sci | 2020 | https://conductscience.org/library/papers/31983608 | PubMed |
| 17 | 26098639 | Antioxidant Activity of Caffeic Acid against Iron-Induced Free Radical Generation--A Chemical Approach. | PLoS One | 2015 | https://conductscience.org/library/papers/26098639 | PubMed |
| 18 | 30377214 | Pharmacological Inhibition of the Temperature-Sensitive and Ca2+-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel by Natural Forsythoside B Attenuates Pruritus and Cytotoxicity of Keratinocytes. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/30377214 | PubMed |
| 19 | 31152005 | Pharmacological Activation of Thermo-Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/31152005 | PubMed |
| 20 | 36979447 | Novel Insights into the Role of Keratinocytes-Expressed TRPV3 in the Skin. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979447 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42828676 | Lifestyle-Driven Phenotypes in Sensitive Skin: A Cross-Sectional, Multicenter Study Across Urbanization Tiers. | Dermatol Ther (Heidelb) | 2026 | https://conductscience.org/library/papers/42828676 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TRPA1 | 8989 | PubTator's text mining | https://conductscience.org/library/genes/8989 | NCBI Gene |
| TRPM8 | 79054 | PubTator's text mining | https://conductscience.org/library/genes/79054 | NCBI Gene |
| TRPV1 | 7442 | PubTator's text mining | https://conductscience.org/library/genes/7442 | NCBI Gene |
| TRPV3 | 162514 | PubTator's text mining | https://conductscience.org/library/genes/162514 | NCBI Gene |
| TRPV4 | 59341 | PubTator's text mining | https://conductscience.org/library/genes/59341 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39202808
GET https://conductscience.org/api/papers/v1/39202808/references?page=2